Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Oruka Therapeutics, Inc. ORKA

Set alert

Price alert · ORKA

All alert types
95.43 USD -1.44 -1.49%

At close · Nov 2

95.43 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
95.44 × 2
Ask
95.55 × 2
94.29 Day range 99.83
25.23 52-week range 115.52
YTD
+214.85%
1 year
+238.76%
Open
98.85
Prev close
96.87
Mkt cap
6.32B
Vol
654.34K
Avg vol
890.09K
EPS
-2.04
P/E
0.00
Div yield
0.00%
More statistics
Low
94.29
High
99.83
Forward P/E
-33.34
Beta
-0.17
Short ratio
5.86
Inst. own
116.96%
Dividend
0.00
Ex-div date
Earnings
Nov 11, 2026
50-d avg
88.47
200-d avg
69.23
1y target
156.17

5D chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 27, 2026Rating: Wedbush · Outperform → Outperform
  • Oct 27, 2026Rating: Guggenheim · Buy → Buy
Signals (114)
NameTimeAgo
SMA: BearishNov 2, 10:10 AM21 hours ago
MACD: Sell SignalNov 2, 10:05 AM21 hours ago
SMA: BearishNov 2, 10:00 AM21 hours ago
SMA: BullishNov 2, 9:50 AM21 hours ago
SMA: BearishNov 2, 9:40 AM21 hours ago
RSI: OverboughtNov 2, 9:30 AM22 hours ago
RSI: OverboughtOct 30, 3:45 PM3 days ago
SMA: BullishOct 30, 3:20 PM3 days ago
SMA: BullishOct 30, 3:20 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
SMA: BullishOct 30, 2:45 PM3 days ago
SMA: BullishOct 30, 2:45 PM3 days ago
SMA: BearishOct 30, 2:35 PM3 days ago
SMA: BearishOct 30, 2:25 PM3 days ago
SMA: BullishOct 30, 2:20 PM3 days ago
SMA: BullishOct 30, 2:20 PM3 days ago
SMA: BearishOct 30, 2:10 PM3 days ago
SMA: BearishOct 30, 2:10 PM3 days ago
SMA: BullishOct 30, 1:45 PM3 days ago

Newest 20 of 114.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 156.17 +63.6% upside
Target (low)
117.00
Target (mean)
156.17
Target (high)
200.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy11
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 13
  • 1 month ago 13
  • 2 months ago 13

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ORKA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.61832-0.79 – -0.41-0.55-12.4%00.0%9
Next quarter-0.6627-0.86 – -0.40-0.45-47.3%00.0%9
Current year-2.37-2.90 – -1.83-1.85-27.9%00.0%9
Next year-2.86-4.09 – -2.19-2.37-21.0%00.0%9

Upgrades and downgrades

The latest rating changes

ORKA analyst upgrades and downgrades
DateFirmActionFromTo
Oct 27, 2026GuggenheimReiteratedBuyBuy
Oct 27, 2026WedbushReiteratedOutperformOutperform
Oct 19, 2026BTIGReiteratedBuyBuy
Sep 24, 2026WedbushReiteratedOutperformOutperform
Sep 24, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 3, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 11, 2026GuggenheimReiteratedBuyBuy
Aug 11, 2026WedbushReiteratedOutperformOutperform
Aug 11, 2026BTIGReiteratedBuyBuy
Aug 3, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jul 13, 2026BTIGReiteratedBuyBuy
Jul 1, 2026UBSMaintainedBuyBuy
Jun 23, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 18, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2026BTIGReiteratedBuyBuy
Apr 29, 2026HC Wainwright & Co.MaintainedBuyBuy
Apr 28, 2026UBSMaintainedBuyBuy
Apr 28, 2026BarclaysMaintainedOverweightOverweight
Apr 27, 2026BTIGMaintainedBuyBuy
Apr 15, 2026WedbushMaintainedOutperformOutperform
Apr 13, 2026GuggenheimReiteratedBuyBuy
Apr 13, 2026BTIGMaintainedBuyBuy
Apr 13, 2026HC Wainwright & Co.MaintainedBuyBuy
Apr 9, 2026GuggenheimReiteratedBuyBuy
Apr 7, 2026BarclaysMaintainedOverweightOverweight
Apr 6, 2026UBSMaintainedBuyBuy
Apr 6, 2026GuggenheimMaintainedBuyBuy
Mar 16, 2026Leerink PartnersMaintainedOutperformOutperform
Mar 13, 2026BarclaysMaintainedOverweightOverweight
Mar 13, 2026BTIGReiteratedBuyBuy